Question 0 of 18

Drug Classification  ·  Questions 1–6

Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.

Question 1

Which of the following correctly classifies mebendazole within the anthelmintic drug classes?

  • AMacrocyclic lactone
  • BBenzimidazole
  • CNicotinic receptor agonist
  • DPrazinoisoquinoline

Correct Answer

B — Benzimidazole

Rationale

Mebendazole belongs to the benzimidazole class of anthelmintics, along with albendazole and thiabendazole. All benzimidazoles share a bicyclic benzene-imidazole scaffold and act by inhibiting tubulin polymerization in susceptible helminths. Macrocyclic lactones are represented by ivermectin. Nicotinic receptor agonists are represented by pyrantel pamoate, which causes depolarizing neuromuscular blockade. Prazinoisoquinolines are represented by praziquantel, which targets flukes and tapeworms.

Question 2

Which of the following correctly classifies ivermectin within the anthelmintic drug classes?

  • ABenzimidazole
  • BNicotinic receptor agonist
  • CMacrocyclic lactone
  • DPentavalent antimonial

Correct Answer

C — Macrocyclic lactone

Rationale

Ivermectin is a macrocyclic lactone — a class of large-ring lactone compounds derived from Streptomyces avermitilis fermentation. Macrocyclic lactones act by opening glutamate-gated chloride channels in invertebrate nerve and muscle tissue. Benzimidazoles (mebendazole, albendazole) act by inhibiting tubulin polymerization. Nicotinic receptor agonists (pyrantel pamoate) cause depolarizing neuromuscular blockade. Pentavalent antimonials target Leishmania and are not anthelmintic agents.

Question 3

Which of the following correctly identifies the primary helminth groups targeted by praziquantel?

  • ACestodes and trematodes
  • BIntestinal nematodes only
  • CFilarial nematodes only
  • DAll helminth classes with equal efficacy

Correct Answer

A — Cestodes and trematodes

Rationale

Praziquantel is active against cestodes (tapeworms) and trematodes (flukes), including Schistosoma species, liver flukes, and most intestinal tapeworm infections. It is not effective against nematodes (roundworms), which lack the calcium channel targets through which praziquantel acts. Intestinal nematodes are treated with benzimidazoles or pyrantel pamoate. Filarial nematodes are treated with ivermectin or diethylcarbamazine. Praziquantel does not have meaningful activity across all helminth classes.

Question 4

Which of the following correctly classifies pyrantel pamoate by its pharmacological mechanism of action?

  • ABenzimidazole tubulin inhibitor
  • BMacrocyclic lactone chloride channel opener
  • CPrazinoisoquinoline calcium channel activator
  • DNicotinic acetylcholine receptor agonist

Correct Answer

D — Nicotinic acetylcholine receptor agonist

Rationale

Pyrantel pamoate is a nicotinic acetylcholine receptor agonist. It produces sustained depolarization at the helminth neuromuscular junction, causing spastic paralysis and expulsion of the worm from the gastrointestinal tract. Benzimidazole tubulin inhibition describes mebendazole and albendazole. Macrocyclic lactone chloride channel opening describes ivermectin. Prazinoisoquinoline calcium channel activation describes praziquantel. Each drug class acts through a distinct receptor or molecular target at the helminth neuromuscular junction or tegument.

Question 5

Among the benzimidazole anthelmintics, which is preferred for tissue-invasive helminthiasis such as neurocysticercosis or echinococcosis?

  • AMebendazole, because it achieves higher peak plasma concentrations than albendazole after oral dosing
  • BAlbendazole, because it is substantially absorbed after oral administration and reaches therapeutic concentrations in systemic tissues
  • CMebendazole, because it is preferentially distributed to the central nervous system due to high lipophilicity
  • DAlbendazole, because it inhibits a broader range of tubulin isoforms than mebendazole and is therefore more potent against tissue stages

Correct Answer

B — Albendazole, because it is substantially absorbed after oral administration and reaches therapeutic concentrations in systemic tissues

Rationale

The key distinction between the two benzimidazoles in clinical use is oral bioavailability. Albendazole is meaningfully absorbed from the gastrointestinal tract — absorption is further enhanced by a fatty meal — and its active sulfoxide metabolite circulates systemically, reaching larval cysts in the liver, lung, muscle, and central nervous system. Mebendazole is very poorly absorbed and acts almost exclusively within the intestinal lumen; it does not achieve systemic tissue concentrations sufficient to treat larval stages in tissues. This pharmacokinetic difference, not a difference in mechanism or potency, explains why albendazole is preferred for tissue-invasive helminthiasis.

Question 6

Which of the following correctly identifies the primary indication for diethylcarbamazine among the anthelmintic drug classes?

  • AIntestinal nematode infections such as ascariasis and trichuriasis
  • BCestode infections such as taeniasis and echinococcosis
  • CFilarial nematode infections such as lymphatic filariasis and tropical pulmonary eosinophilia
  • DTrematode infections such as schistosomiasis and liver fluke disease

Correct Answer

C — Filarial nematode infections such as lymphatic filariasis and tropical pulmonary eosinophilia

Rationale

Diethylcarbamazine is indicated for filarial infections, including lymphatic filariasis caused by Wuchereria bancrofti and Brugia species, and tropical pulmonary eosinophilia. It is also active against Loa loa but must be used cautiously in co-endemic areas due to encephalopathy risk. Intestinal nematodes (ascariasis, trichuriasis, hookworm) are treated with benzimidazoles or pyrantel pamoate. Cestode infections are treated with praziquantel or albendazole. Trematode infections are treated with praziquantel.

Core Pharmacology  ·  Questions 7–14

Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.

Question 7

Mebendazole and albendazole are effective against a broad range of intestinal nematodes. Which of the following best explains how these drugs kill susceptible helminths?

  • AThey bind to parasite tubulin and inhibit its polymerization into microtubules, disrupting microtubule-dependent processes including glucose uptake, leading to parasite energy depletion and death
  • BThey open glutamate-gated chloride channels in the parasite nervous system, causing hyperpolarization and flaccid paralysis followed by expulsion
  • CThey increase calcium permeability across the parasite tegument, causing muscle spasm and tegument disruption that exposes the worm to immune attack
  • DThey act as nicotinic acetylcholine receptor agonists at the helminth neuromuscular junction, producing sustained depolarization and spastic paralysis

Correct Answer

A — They bind to parasite tubulin and inhibit its polymerization into microtubules, disrupting microtubule-dependent processes including glucose uptake, leading to parasite energy depletion and death

Rationale

Benzimidazoles bind selectively to parasite beta-tubulin and prevent its assembly into microtubules. Helminths depend on intact microtubules for glucose uptake across the intestinal epithelium; disruption of microtubule function deprives the parasite of its primary energy source, leading to immobilization and death over days. The selectivity for parasite tubulin over mammalian tubulin accounts for the favorable safety profile of these drugs at therapeutic doses. Glutamate-gated chloride channel opening describes ivermectin. Calcium permeability increase describes praziquantel. Nicotinic receptor agonism describes pyrantel pamoate.

Question 8

Mebendazole and albendazole share the same mechanism of action against intestinal helminths, yet albendazole is used for tissue-invasive infections while mebendazole is not. Which of the following best explains this difference in clinical application?

  • AAlbendazole is more potent than mebendazole against larval stages because its active metabolite has higher intrinsic affinity for larval tubulin isoforms
  • BMebendazole is rapidly degraded by gastric acid before reaching the small intestine, while albendazole is acid-stable and therefore better absorbed
  • CAlbendazole is substantially absorbed from the gastrointestinal tract and its active metabolite circulates systemically, reaching larval cysts in tissues; mebendazole is poorly absorbed and acts only within the intestinal lumen
  • DMebendazole is actively effluxed by intestinal P-glycoprotein before absorption, while albendazole evades this efflux mechanism and achieves higher plasma levels

Correct Answer

C — Albendazole is substantially absorbed from the gastrointestinal tract and its active metabolite circulates systemically, reaching larval cysts in tissues; mebendazole is poorly absorbed and acts only within the intestinal lumen

Rationale

The clinical difference between these two benzimidazoles is pharmacokinetic, not pharmacodynamic. Mebendazole is very poorly absorbed after oral administration — the vast majority of a dose remains in the intestinal lumen, where it acts against adult worms. Albendazole is meaningfully absorbed, and its active sulfoxide metabolite achieves systemic circulation, distributing into tissues including the liver, lung, muscle, and central nervous system where larval cysts reside. Taking albendazole with a fatty meal further improves absorption. Tissue-invasive helminthiasis — neurocysticercosis, echinococcosis, visceral larva migrans — requires a drug that reaches larval stages systemically, which only albendazole achieves. The difference is not due to differential tubulin affinity, gastric acid stability, or P-glycoprotein efflux.

Question 9

Ivermectin is effective against a wide range of nematode and ectoparasite infections yet is well tolerated in mammals at therapeutic doses. Which of the following best explains both ivermectin's mechanism of antiparasitic activity and its selective safety in vertebrates?

  • AIvermectin inhibits tubulin polymerization selectively in invertebrate cells because vertebrate tubulin contains a substitution at the ivermectin binding site that prevents drug binding
  • BIvermectin opens glutamate-gated chloride channels present in invertebrate nerve and muscle, causing hyperpolarization and paralysis; vertebrates lack these channels, making the drug selectively toxic to invertebrates
  • CIvermectin acts as a nicotinic acetylcholine receptor agonist in helminths but is rapidly inactivated by cholinesterases in vertebrate plasma before it can reach the vertebrate neuromuscular junction
  • DIvermectin increases calcium permeability in the helminth tegument and is selectively safe in vertebrates because mammalian calcium channels have a different subunit composition that confers resistance

Correct Answer

B — Ivermectin opens glutamate-gated chloride channels present in invertebrate nerve and muscle, causing hyperpolarization and paralysis; vertebrates lack these channels, making the drug selectively toxic to invertebrates

Rationale

Ivermectin binds to and opens glutamate-gated chloride channels — ion channels found in invertebrate nerve and muscle tissue that have no vertebrate equivalent. Channel opening increases chloride conductance, hyperpolarizing the cell membrane and producing flaccid paralysis of the parasite. Because vertebrates do not express glutamate-gated chloride channels, the drug has no equivalent pharmacological target in mammalian tissue, explaining its wide therapeutic window. At very high doses or in patients with compromised blood-brain barrier function, ivermectin can cause central nervous system toxicity in vertebrates through interaction with gamma-aminobutyric acid receptors — but this does not occur at therapeutic doses. Tubulin binding, cholinesterase inactivation, and calcium channel differences are not the basis for ivermectin's mechanism or selectivity.

Question 10

Ivermectin is used for mass drug administration programs targeting onchocerciasis and lymphatic filariasis in sub-Saharan Africa. In some regions, however, mass administration of ivermectin is contraindicated due to the risk of a severe neurological complication. Which of the following best explains this safety constraint?

  • AIvermectin is hepatically metabolized to a neurotoxic metabolite that accumulates in patients with underlying liver disease, which is prevalent in sub-Saharan African populations
  • BIvermectin crosses the blood-brain barrier in patients with onchocerciasis because the parasite disrupts tight junction proteins in cerebral endothelial cells
  • CRapid killing of adult Onchocerca volvulus worms releases toxic prostaglandins that cause encephalopathy through a systemic inflammatory mechanism
  • DIn areas co-endemic for Loa loa, patients with high Loa loa microfilaria burdens can develop encephalopathy when rapid killing of microfilariae in the central nervous system causes severe local inflammation

Correct Answer

D — In areas co-endemic for Loa loa, patients with high Loa loa microfilaria burdens can develop encephalopathy when rapid killing of microfilariae in the central nervous system causes severe local inflammation

Rationale

The Loa loa safety constraint is one of the most important practical limitations of ivermectin mass drug administration. Loa loa is a filarial nematode co-endemic with onchocerciasis and lymphatic filariasis across central and West Africa. Patients with high Loa loa microfilaria burdens in the bloodstream are at risk for encephalopathy after ivermectin treatment because rapid killing of large numbers of microfilariae within central nervous system vessels triggers a severe local inflammatory response. This complication is rare but can be fatal. As a result, pre-treatment screening for Loa loa burden or use of alternative agents such as diethylcarbamazine is required before mass drug administration in co-endemic regions. The risk is not due to a neurotoxic metabolite, parasite disruption of the blood-brain barrier, or adult worm killing.

Question 11

Praziquantel is the treatment of choice for schistosomiasis, tapeworm infections, and most other fluke infections. Which of the following best explains how praziquantel kills susceptible helminths?

  • APraziquantel increases calcium permeability in susceptible helminths, causing tetanic muscle contraction, tegument disruption, and exposure of parasite surface antigens to host immune attack
  • BPraziquantel inhibits tubulin polymerization in flukes and tapeworms, disrupting microtubule-dependent tegument maintenance and causing worm death
  • CPraziquantel opens glutamate-gated chloride channels in trematodes and cestodes, causing hyperpolarization and flaccid paralysis followed by immune clearance
  • DPraziquantel acts as a nicotinic receptor agonist at the trematode neuromuscular junction, producing sustained depolarization and expulsion from the host vascular system

Correct Answer

A — Praziquantel increases calcium permeability in susceptible helminths, causing tetanic muscle contraction, tegument disruption, and exposure of parasite surface antigens to host immune attack

Rationale

Praziquantel acts by dramatically increasing calcium influx across the tegument of susceptible helminths. The resulting surge in intracellular calcium causes rapid tetanic muscle contraction and disrupts the structural integrity of the tegument — the parasite's outer surface layer. Tegument disruption exposes surface antigens previously hidden from the host immune system, allowing antibody-mediated and cellular immune mechanisms to participate in parasite killing. The combination of physical tegument damage and immune-mediated attack produces rapid worm death. Praziquantel does not inhibit tubulin, open glutamate-gated chloride channels, or act at nicotinic receptors — those are the mechanisms of benzimidazoles, ivermectin, and pyrantel pamoate respectively.

Question 12

A patient with schistosomiasis and concurrent pulmonary tuberculosis requires treatment with both praziquantel and rifampin. Which of the following best explains why this drug combination requires careful management?

  • ARifampin competitively inhibits praziquantel binding to its target receptor, directly reducing the drug's antiparasitic potency
  • BPraziquantel inhibits rifampin absorption in the gastrointestinal tract, reducing rifampin plasma levels and risking tuberculosis treatment failure
  • CRifampin induces hepatic drug-metabolizing enzymes, accelerating praziquantel metabolism and reducing praziquantel plasma levels below therapeutic concentrations
  • DBoth drugs are nephrotoxic, and co-administration increases the risk of acute kidney injury requiring dose reduction of both agents

Correct Answer

C — Rifampin induces hepatic drug-metabolizing enzymes, accelerating praziquantel metabolism and reducing praziquantel plasma levels below therapeutic concentrations

Rationale

Rifampin is one of the most potent inducers of hepatic drug-metabolizing enzymes in clinical use. When praziquantel is co-administered with rifampin, hepatic metabolism of praziquantel is markedly accelerated, reducing praziquantel plasma concentrations — in some cases to subtherapeutic levels — and risking treatment failure for the helminth infection. This interaction is clinically relevant because schistosomiasis and tuberculosis co-occur in overlapping geographic regions. When rifampin-based tuberculosis treatment cannot be deferred, praziquantel dose adjustment or an alternative anthelmintic strategy may be required. The interaction is entirely pharmacokinetic — rifampin does not block praziquantel at its target, praziquantel does not affect rifampin absorption, and neither drug causes clinically significant nephrotoxicity at standard doses.

Question 13

Pyrantel pamoate is used for intestinal nematode infections including pinworm and roundworm. Which of the following best explains how pyrantel pamoate kills susceptible helminths?

  • APyrantel pamoate opens glutamate-gated chloride channels in the helminth nervous system, hyperpolarizing the cell membrane and causing flaccid paralysis
  • BPyrantel pamoate acts as a nicotinic acetylcholine receptor agonist at the helminth neuromuscular junction, producing sustained depolarization and spastic paralysis followed by expulsion
  • CPyrantel pamoate inhibits tubulin polymerization in nematodes, disrupting microtubule-dependent glucose uptake and leading to parasite energy depletion
  • DPyrantel pamoate increases calcium permeability in the nematode tegument, causing muscle spasm and surface disruption that exposes the worm to host immune clearance

Correct Answer

B — Pyrantel pamoate acts as a nicotinic acetylcholine receptor agonist at the helminth neuromuscular junction, producing sustained depolarization and spastic paralysis followed by expulsion

Rationale

Pyrantel pamoate mimics acetylcholine at nicotinic receptors on the helminth neuromuscular junction. Unlike acetylcholine, it is not broken down by cholinesterase, so its depolarizing action is sustained. Persistent depolarization produces spastic paralysis of the worm, which is then expelled by normal intestinal peristalsis. Because pyrantel pamoate is poorly absorbed from the gastrointestinal tract, it acts locally within the intestinal lumen with minimal systemic exposure and a favorable safety profile. Glutamate-gated chloride channel opening describes ivermectin. Tubulin inhibition describes benzimidazoles. Calcium permeability increase describes praziquantel.

Question 14

Diethylcarbamazine is used for lymphatic filariasis and other filarial infections. Which of the following best explains how diethylcarbamazine produces its antiparasitic effect?

  • ADiethylcarbamazine opens glutamate-gated chloride channels in filarial nematodes, causing hyperpolarization and flaccid paralysis of microfilariae
  • BDiethylcarbamazine inhibits tubulin polymerization in filarial larvae, blocking microtubule-dependent processes required for microfilarial motility
  • CDiethylcarbamazine acts as a direct filaricidal agent, generating reactive oxygen species within microfilariae that cause rapid oxidative parasite death
  • DDiethylcarbamazine immobilizes microfilariae and alters their surface properties, enhancing recognition and destruction by the host immune system rather than acting by direct toxicity alone

Correct Answer

D — Diethylcarbamazine immobilizes microfilariae and alters their surface properties, enhancing recognition and destruction by the host immune system rather than acting by direct toxicity alone

Rationale

Diethylcarbamazine's mechanism is distinct from the other anthelmintics in this chapter in that it does not act primarily through direct parasite toxicity. Instead, it immobilizes microfilariae and alters properties of their surface, making them more susceptible to recognition and destruction by host immune effector cells. This immune-dependent mechanism explains why diethylcarbamazine is more effective against microfilariae than against adult worms, and why it is less effective in immunocompromised hosts. It does not open glutamate-gated chloride channels, inhibit tubulin, or generate reactive oxygen species as its primary mechanism.

Clinical Correlations  ·  Questions 15–18

Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.

Question 15

A 58-year-old man who received a renal transplant six weeks ago is admitted with fever, severe abdominal pain, and septic shock. Blood cultures grow gram-negative rods. Stool examination reveals Strongyloides stercoralis filariform larvae. He has been on tacrolimus and high-dose prednisone since transplantation. Which of the following best explains why this patient developed life-threatening septicemia in the setting of Strongyloides infection?

  • AStrongyloides larvae release endotoxin directly into the portal circulation, triggering gram-negative sepsis without requiring bowel wall disruption
  • BImmunosuppression permits unchecked larval amplification; filariform larvae penetrate the bowel wall and carry intestinal bacteria into the bloodstream, causing gram-negative septicemia — the hyperinfection syndrome that ivermectin treatment before immunosuppression is designed to prevent
  • CTacrolimus directly activates Strongyloides larval maturation to the filariform stage, converting a dormant infection into an invasive one regardless of immune status
  • DStrongyloides hyperinfection occurs because corticosteroids increase intestinal permeability, allowing rhabditiform larvae to enter the bloodstream through epithelial tight junctions

Correct Answer

B — Immunosuppression permits unchecked larval amplification; filariform larvae penetrate the bowel wall and carry intestinal bacteria into the bloodstream, causing gram-negative septicemia — the hyperinfection syndrome that ivermectin treatment before immunosuppression is designed to prevent

Rationale

Strongyloides stercoralis is unique among intestinal helminths in its ability to complete its entire life cycle within a single host through autoinfection. In immunocompetent individuals, this autoinfection cycle is kept in check by immune surveillance. When T-cell immunity is suppressed — as in this patient receiving tacrolimus and high-dose corticosteroids after transplantation — larval amplification proceeds unchecked, producing massive numbers of filariform larvae. These invasive larvae penetrate the intestinal wall and carry intestinal bacteria with them into the mesenteric lymphatics and systemic circulation, causing gram-negative septicemia and meningitis. This is the hyperinfection syndrome, and it carries high mortality. The bacteria are physically transported by the larvae through the bowel wall — not released as endotoxin, not activated by tacrolimus, and not entering through tight junctions.

Question 16

A 45-year-old woman from a Strongyloides-endemic region is evaluated before starting immunosuppressive therapy for a kidney transplant. Serological testing is positive for Strongyloides stercoralis but she has no gastrointestinal symptoms. Her transplant physician explains that treatment before transplantation is mandatory. Which of the following best explains what would happen if Strongyloides infection is left untreated and immunosuppression is started?

  • ALoss of T-cell immune control would allow autoinfection to amplify unchecked, potentially producing hyperinfection syndrome with larval dissemination, bowel wall penetration, and life-threatening gram-negative septicemia; pre-treatment with ivermectin eliminates this risk
  • BImmunosuppressive drugs would directly stimulate Strongyloides egg production, causing acute intestinal obstruction from massive worm burden within weeks of transplantation
  • CThe transplanted kidney would become the primary site of Strongyloides larval deposition, causing organ rejection through a parasite-mediated immune response
  • DStrongyloides would remain confined to the intestinal lumen regardless of immune status, causing only mild gastrointestinal symptoms that would not affect transplant outcomes

Correct Answer

A — Loss of T-cell immune control would allow autoinfection to amplify unchecked, potentially producing hyperinfection syndrome with larval dissemination, bowel wall penetration, and life-threatening gram-negative septicemia; pre-treatment with ivermectin eliminates this risk

Rationale

Strongyloides stercoralis can persist for decades in a human host as a low-level, asymptomatic infection held in check by intact T-cell immunity. When that immunity is removed by transplant immunosuppression, the autoinfection cycle accelerates without limit. The resulting hyperinfection syndrome causes larval invasion of the bowel wall and dissemination to lungs, liver, central nervous system, and other organs, with concurrent transport of intestinal bacteria into the bloodstream. The outcome is gram-negative septicemia and meningitis with high mortality. This is why all candidates for organ transplantation who have lived in or traveled to Strongyloides-endemic regions must be screened and treated before immunosuppression begins — a course of ivermectin clears the infection and prevents this complication. Immunosuppressive drugs do not stimulate egg production, the transplanted organ is not a site of larval deposition, and Strongyloides does not remain confined to the intestinal lumen under immunosuppression.

Question 17

A 29-year-old woman presents with right upper quadrant pain, fever, and eosinophilia after consuming watercress in a rural region of South America. Serological testing and imaging confirm Fasciola hepatica infection of the bile ducts. She is treated with a standard course of praziquantel but fails to clear the infection. Which of the following best explains this treatment failure?

  • APraziquantel is rapidly inactivated by bile salts in the biliary system, preventing therapeutic concentrations from reaching Fasciola organisms within the bile ducts
  • BFasciola hepatica expresses an efflux transporter that actively removes praziquantel from the tegument before calcium influx can occur
  • CPraziquantel requires hepatic activation to its active metabolite, but biliary obstruction caused by Fasciola prevents this metabolic conversion
  • DFasciola hepatica is intrinsically resistant to praziquantel; triclabendazole is the drug of choice for this infection

Correct Answer

D — Fasciola hepatica is intrinsically resistant to praziquantel; triclabendazole is the drug of choice for this infection

Rationale

Praziquantel is highly effective against most trematodes and cestodes, but Fasciola hepatica is a well-established exception — it is intrinsically resistant to praziquantel at clinically achievable concentrations. The mechanism of this resistance is not fully characterized, but it is a consistent finding that distinguishes Fasciola from other liver flukes such as Clonorchis sinensis and Opisthorchis species, which do respond to praziquantel. The correct treatment for Fasciola hepatica infection is triclabendazole, a benzimidazole derivative with a distinct mechanism that is active against Fasciola at both larval and adult stages. Recognizing this exception is clinically important because empirical praziquantel therapy for presumed liver fluke disease will fail when Fasciola is the causative organism. Biliary inactivation, efflux transporters, and a requirement for hepatic metabolic activation are not the explanation for praziquantel's failure against Fasciola.

Question 18

A 31-year-old man from West Africa is treated with diethylcarbamazine for onchocerciasis. Within two hours of the first dose he develops high fever, severe pruritus, an urticarial rash, and hypotension. He has not taken this drug before. Which of the following best explains the mechanism of this reaction?

  • ADiethylcarbamazine caused an IgE-mediated type I hypersensitivity reaction in a patient who was previously sensitized to a cross-reacting antigen
  • BDiethylcarbamazine is directly toxic to mast cells, causing non-immunological degranulation and systemic histamine release at standard therapeutic doses
  • CRapid killing of large numbers of microfilariae releases parasite antigens that trigger a host inflammatory response; the reaction reflects the parasite burden, not drug toxicity
  • DDiethylcarbamazine inhibits aldehyde dehydrogenase, causing accumulation of a toxic metabolite that produces fever and vasodilation within hours of the first dose

Correct Answer

C — Rapid killing of large numbers of microfilariae releases parasite antigens that trigger a host inflammatory response; the reaction reflects the parasite burden, not drug toxicity

Rationale

The Mazzotti reaction is a systemic inflammatory response that occurs when diethylcarbamazine rapidly kills large numbers of Onchocerca volvulus microfilariae. The sudden release of parasite antigens from dying microfilariae triggers host immune and inflammatory mediator release, producing fever, pruritus, rash, and hypotension — a reaction whose severity is proportional to the microfilarial burden rather than to the drug dose. It is not a drug allergy, not direct mast cell toxicity, and not a toxic metabolite effect. Management is with antihistamines and corticosteroids to blunt the inflammatory response; the reaction is not a reason to discontinue diethylcarbamazine, and it is expected to be less severe with subsequent doses as microfilarial burden decreases.